We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,341 results
  1. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates

    Background

    Multidrug-resistant organism (MDRO) screening may identify high-risk patients for MDRO infection and curb the spread of these resistant...

    Sungsoo Park, Heesuk Kim, ... Hyeyoung Oh in Antimicrobial Resistance & Infection Control
    Article Open access 28 November 2023
  2. The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data

    Surveillance has revealed an increase of multidrug-resistant organisms (MDROs), even in low-prevalent settings such as Norway. MDROs pose a...

    Anders Skyrud Danielsen, Petter Elstrøm, ... Jørgen Vildershøj Bjørnholt in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 18 November 2023
  3. Antimicrobial Nanofibers to Fight Multidrug-Resistant Bacteria

    Multidrug-resistant bacteria are among the most challenges in healthcare systems. According to the World Health Organization, these bacteria that...
    Carolina A. M. Ferreira, Sara F. C. Guerreiro, ... Juliana R. Dias in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  4. Polymer-Based Nanomaterials Against Multidrug-Resistant Bacteria

    Currently, there are major developments in the fields of medicine and biomedical engineering to mitigate the spreading of resistant bacteria and the...
    Ana R. M. Ribeiro, Marta O. Teixeira, ... Helena P. Felgueiras in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  5. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms

    Background

    Multidrug-resistant organisms (MDROs) such as vancomycin-resistant enterococci (VRE) and carbapenemase-producing Enterobacteriaceae (CPE)...

    JongHoon Hyun, Sang Kil Lee, ... Jun Yong Choi in Antimicrobial Resistance & Infection Control
    Article Open access 29 January 2022
  6. Antimicrobial Peptide-Based Nanomaterials in Combating Multidrug-Resistant Bacteria

    The escalated increase in morbidity and mortality in the recent era has resulted due to the impact of antimicrobial resistance (AMR) among...
    Anindita Thakur, Ramakrishnan Ganesan, Jayati Ray Dutta in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  7. Silver Nanoparticles as Potent Multidrug-Resistant Incorporants in Biomedicine

    Antimicrobial resistance threatens the effective treatment of ever increasing infections caused by various microorganisms. Antimicrobial potential of...
    Imran Uddin, Divya S. Parimi, ... Anil K. Suresh in Emerging Modalities in Mitigation of Antimicrobial Resistance
    Chapter 2022
  8. Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program

    Background

    Currently, different guidelines recommend using different methods to determine whether deduplication is necessary when determining the...

    Zhanjie Li, Dan Zhu, ... ** Zhu in Antimicrobial Resistance & Infection Control
    Article Open access 21 May 2024
  9. Green-Synthesized Nanoparticles to Combat Multidrug-Resistant Bacteria

    Antibiotic resistance has rapidly climbed in recent years, threatening millions of lives worldwide and presenting a serious threat to community...
    Rutuja S. Palaskar, Darshana S. Dhokane, Balaprasad G. Ankamwar in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  10. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey

    Evaluating trends in antibiotic resistance is a requisite. The study aimed to analyze the profile of multidrug-resistant organisms (MDROs) among...

    Rehab El-Sokkary, Serhat Uysal, ... Jordi Rello in European Journal of Clinical Microbiology & Infectious Diseases
    Article 21 June 2021
  11. Zoonotic and Multidrug-Resistant Bacteria in Companion Animals Challenge Infection Medicine and Biosecurity

    At present, various zoonotic and multidrug resistant (MDR) bacteria, including but not limited to Staphylococcus aureus and Escherichia coli, are...
    Birgit Walther, Katharina Schaufler, ... Antina Lübke-Becker in Zoonoses: Infections Affecting Humans and Animals
    Reference work entry 2023
  12. Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors

    Identification of risk factors influencing the duration of carriage of multidrug-resistant Gram-negative bacilli (MDR-GNB) may be useful for...

    S. Herrera, B. Torralbo, ... J. A. Martinez in European Journal of Clinical Microbiology & Infectious Diseases
    Article 25 March 2023
  13. Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria

    Multidrug-resistant (MDR) bacteria are considered a health threat worldwide, and this problem is set to increase over the decades. The ESKAPE, a...

    Bernardo Cavallazzi Sebold, Junjie Li, ... Tianfang Wang in BioDrugs
    Article Open access 10 June 2023
  14. Metabolomics unveil key pathways underlying the synergistic activities of aztreonam and avibactam against multidrug-resistant Escherichia coli

    Purpose

    Aztreonam/avibactam is effective against serious infections caused by Gram-negative bacteria including Enterobacterales harboring...

    Xuefeng Zhou, Jiayuan Zhang, ... Hai Yang in European Journal of Clinical Microbiology & Infectious Diseases
    Article 09 May 2024
  15. Phylogenomic insights into evolutionary trajectories of multidrug resistant S. pneumoniae CC271 over a period of 14 years in China

    Background

    Streptococcus pneumoniae is a gram-positive opportunistic pathogen, and infection risks of S. pneumoniae can be profoundly augmented by...

    Yuan Zeng, Yuqin Song, ... Jie Feng in Genome Medicine
    Article Open access 04 July 2023
  16. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review

    Background

    Multidrug resistant organisms (MDROs) occur more commonly in burns patients than in other hospital patients and are an increasingly...

    Heather Cleland, Lincoln M. Tracy, ... Andrew J. Stewardson in Antimicrobial Resistance & Infection Control
    Article Open access 13 June 2022
  17. Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study

    Background

    Patients admitted to intensive care units (ICU) are at risk of Gram-negative bacteria (GNB) infections, especially those caused by...

    Jane Wairimu Maina, Frank Gekara Onyambu, ... Abednego Moki Musyoki in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 14 September 2023
  18. Epidemiology of multidrug-resistant Klebsiella pneumoniae infection in clinical setting in South-Eastern Asia: a systematic review and meta-analysis

    The rising prevalence of multidrug-resistant (MDR) and extended-spectrum beta lactamase-resistant (ESBL) Klebsiella pneumoniae ( K. pneumoniae ) is an...

    Adamu Salawudeen, Yakubu Egigogo Raji, ... Tengku Zetty Maztura Tengku Jamaluddin in Antimicrobial Resistance & Infection Control
    Article Open access 07 December 2023
  19. Antibacterial, antibiofilm, and antivirulence potential of the main diterpenes from Copaifera spp. oleoresins against multidrug‐resistant bacteria

    To evaluate the antibacterial, antibiofilm and antivirulence potential of the main diterpenes from Copaifera spp. oleoresins against...

    L. F. Leandro, T. S. Moraes, ... C. H. G. Martins in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 April 2024
  20. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature

    Background

    Despite the adoption of strict infection prevention and control measures, many hospitals have reported outbreaks of multidrug-resistant...

    Reto Thoma, Marco Seneghini, ... Philipp Kohler in Antimicrobial Resistance & Infection Control
    Article Open access 21 January 2022
Did you find what you were looking for? Share feedback.